Aerie Pharmaceuticals has built and commenced operation of its GMP (Good Manufacturing Practices)-validated manufacturing facility for production of ophthalmic implants using the proprietary PRINT® (Particle Replication in Non-wetting Templates) Technology platform.  As a result of the compact footprint and efficiency of the PRINT® manufacturing process, the custom-designed 1,000 sq. ft. laboratory provides adequate capacity to produce all of the clinical product supply necessary for Aerie’s ...